Objective: As disruption of epigenetic control is a frequent event in solid tumors and leukemia, we investigated changes in DNA methylation (5mC) and hydroxymethylation (5hmC) in patients with systemic mastocytosis (SM), a rare myeloproliferative disease with a wide spectrum of severity, characterized by the accumulation of mast cells in various organs. Methods: We measured overall genomic levels of 5hmC and 5mC in patients with SM by dot blot, as well as by quantitative immunofluorescence in samples of cutaneous mastocytosis. Results: Overall 5hmC levels were reduced in all patients with SM, but to a greater extent in the presence of higher D816V mutational load in the KIT oncogene, which affects prognosis and therapeutic options in these patients. Loss of 5hmC was likely due to systemic effects of SM as it did not correlate with overall mast cell burden in these patients, nor it was due to inactivating mutations of TET2 or reduced TET2 expression. Conclusions: The correlation between SM diagnosis and significantly low 5hmC levels suggests that reduction of 5hmC represents a systemic effect of SM that may be useful for patient stratification and that measurements of 5hmC levels may serve as a better prognostic marker than TET2 mutations.

Reduced DNA methylation and hydroxymethylation in patients with systemic mastocytosis / C. Leoni, S. Montagner, L. Deho', R. D'Antuono, G. De Matteis, A.V. Marzano, S. Merante, E.M. Orlandi, R. Zanotti, S. Monticelli. - In: EUROPEAN JOURNAL OF HAEMATOLOGY. - ISSN 0902-4441. - 95:6(2015), pp. 566-575.

Reduced DNA methylation and hydroxymethylation in patients with systemic mastocytosis

L. Deho';A.V. Marzano;S. Monticelli
2015

Abstract

Objective: As disruption of epigenetic control is a frequent event in solid tumors and leukemia, we investigated changes in DNA methylation (5mC) and hydroxymethylation (5hmC) in patients with systemic mastocytosis (SM), a rare myeloproliferative disease with a wide spectrum of severity, characterized by the accumulation of mast cells in various organs. Methods: We measured overall genomic levels of 5hmC and 5mC in patients with SM by dot blot, as well as by quantitative immunofluorescence in samples of cutaneous mastocytosis. Results: Overall 5hmC levels were reduced in all patients with SM, but to a greater extent in the presence of higher D816V mutational load in the KIT oncogene, which affects prognosis and therapeutic options in these patients. Loss of 5hmC was likely due to systemic effects of SM as it did not correlate with overall mast cell burden in these patients, nor it was due to inactivating mutations of TET2 or reduced TET2 expression. Conclusions: The correlation between SM diagnosis and significantly low 5hmC levels suggests that reduction of 5hmC represents a systemic effect of SM that may be useful for patient stratification and that measurements of 5hmC levels may serve as a better prognostic marker than TET2 mutations.
5-hydroxymethylation; DNA methylation; Epigenetics; Systemic mastocytosis; TET2; Biopsy; Bone Marrow; Cell Line; DNA-Binding Proteins; Female; Humans; Immunophenotyping; Male; Mast Cells; Mastocytosis, Systemic; Mutation; Proto-Oncogene Proteins; DNA Methylation; Epigenesis, Genetic; Hematology
Settore MED/35 - Malattie Cutanee e Veneree
2015
Article (author)
File in questo prodotto:
File Dimensione Formato  
Leoni-Montagner-Deho - Reduced DNA Methylation and... - (Eur J Haematol 2015).pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 822.73 kB
Formato Adobe PDF
822.73 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Leoni_et_al-2015-European_Journal_of_Haematology.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 825.31 kB
Formato Adobe PDF
825.31 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/554164
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 9
social impact